Medical Science 2021 Paper II 50 marks Discuss

Paper II — Q4

(a) Discuss in short the etiology, diagnosis, treatment and complications of cirrhosis of liver. (5+5+5+5=20 marks) (b) A…

(a)

Discuss in short the etiology, diagnosis, treatment and complications of cirrhosis of liver. (5+5+5+5=20 marks)

(b)
(i)

A 15-month-old child brought by the mother with history of 6 episodes of vomiting and 4 episodes of watery diarrhoea was found to have lethargy and is unable to drink. The child weighed 10 kg before this event of illness. How would you assess the severity of the illness in this child ?

(ii)

Write the fluid management in the first 3 hours.

(iii)

Write the treatment guidelines after 3 hours if the child still exhibits signs of dehydration.

(iv)

Write the composition and preparation of the WHO Oral Rehydration Salts (ORS). (4+4+4+8=20 marks)

(c)
(i)

What is the differential diagnosis of psoriatic arthritis ? How would you distinguish psoriatic arthritis from other conditions ?

(ii)

Discuss the management of psoriatic arthritis. (5+5=10 marks)

हिंदी में प्रश्न पढ़ें
(a)

यकृत सिरोसिस की हेतुकी, निदान, उपचार तथा जटिलताओं की संक्षेप में चर्चा कीजिए । 5+5+5+5=20

(b)
(i)

एक माँ अपने 15 माह के बच्चे को लेकर आती है । इस बच्चे को 6 बार वमन तथा 4 बार जलीय प्रवाहिका के प्रसंग हो चुके हैं, वह निर्जलित है और इस स्थिति में नहीं है कि द्रव पी सके । इस क्षणता से पूर्व बच्चे का वजन 10 kg था । बालक में क्षणता किस तीव्रता की है, यह आकलन आप कैसे करेंगे ?

(ii)

प्रथम तीन घंटों में तरल (फ्लूड) प्रबंधन के लिए क्या करना होगा, लिखिए ।

(iii)

यदि बालक 3 घंटों के बाद भी निर्जलीकरण के लक्षण दर्शाता है, तो उसके उपचार निर्देश क्या होंगे, लिखिए ।

(iv)

डब्ल्यू.एच.ओ. मुखी पुनर्जलीकरण लवण (ओ.आर.एस.) की रचना तथा उसे निर्मित करने की विधि के बारे में लिखिए । 4+4+4+8=20

(c)
(i)

सोरियासिस सन्धिशोथ का विभेदक निदान क्या है ? अन्य रुग्णताओं से सोरियासिस सन्धिशोथ की पहचान आप कैसे करेंगे ?

(ii)

सोरियासिस सन्धिशोथ के प्रबन्धन की चर्चा कीजिए । 5+5=10

Q4 of the 2021 UPSC Mains Medical Science Paper II, as printed
The question as printed in the 2021 Medical Science paper

Model answer

Drafted with AI by UPSC Answer Check against this question's marking rubric, to the expected length. UPSC does not publish answers for Mains — this is one way to score well, not an official key. How we build rubrics and answers.

(a) Cirrhosis of the liver

Cirrhosis is diffuse hepatic fibrosis with regenerative nodules and distorted architecture.

Aetiology: alcohol; chronic hepatitis B and C; metabolic dysfunction-associated fatty liver disease; autoimmune hepatitis; biliary diseases (primary biliary cholangitis, primary sclerosing cholangitis); Wilson disease, haemochromatosis and alpha-1 antitrypsin deficiency; vascular causes (Budd–Chiari syndrome, chronic right heart failure); drugs and cryptogenic causes.

Diagnosis:

  • Clinical: jaundice, spider naevi, palmar erythema, gynaecomastia, ascites, splenomegaly and collaterals.
  • Laboratory: thrombocytopenia, low albumin, prolonged INR, raised bilirubin, AST above ALT in alcohol-related disease.
  • Imaging: ultrasound shows nodular surface, coarse echotexture and portal hypertension; elastography shows stiffness.
  • Upper endoscopy for varices; ascitic fluid analysis; liver biopsy if the cause is uncertain.
  • Severity by Child–Pugh and MELD scores.

Treatment:

  • Treat the cause: alcohol abstinence, antivirals for hepatitis B and C, weight loss, copper chelation in Wilson disease; vaccinate against hepatitis A and B.
  • Varices: non-selective beta-blocker (propranolol or carvedilol) and endoscopic band ligation.
  • Ascites: sodium restriction, spironolactone with furosemide, paracentesis with albumin; norfloxacin or ciprofloxacin prophylaxis after spontaneous bacterial peritonitis.
  • Encephalopathy: lactulose and rifaximin.
  • Hepatorenal syndrome: terlipressin with albumin; TIPS in selected patients.
  • Liver transplantation for decompensated disease; ultrasound every 6 months for hepatocellular carcinoma.

Complications: variceal bleeding, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, coagulopathy, hypersplenism, malnutrition and hepatocellular carcinoma.

(b)(i) Severity of illness

Using the WHO/IMCI assessment: look at general condition, eyes, thirst or ability to drink, and skin pinch. This child is lethargic and unable to drink, which are two signs of severe dehydration (Plan C). Estimated deficit is above 10% of body weight, over 1 kg of the usual 10 kg. Also check for shock (cold extremities, weak pulse, delayed capillary refill).

(b)(ii) Fluids in the first 3 hours

Give intravenous Ringer's lactate (or normal saline) 100 mL/kg (1,000 mL): 30 mL/kg (300 mL) over the first 30 minutes, then 70 mL/kg (700 mL) over the next 2.5 hours (the faster schedule applies to children over 12 months; infants take 1 hour and 5 hours). Offer ORS 5 mL/kg/hour as soon as the child can drink. Reassess every 15–30 minutes.

(b)(iii) After 3 hours

Reassess. If severe dehydration persists, repeat the IV regimen. If some dehydration remains, switch to Plan B (ORS 75 mL/kg over 4 hours); if none, use Plan A, with continued feeding and ORS after each loose stool. Give zinc 20 mg daily for 14 days, continue breastfeeding and normal feeds, and counsel on danger signs and follow-up.

(b)(iv) WHO ORS (reduced osmolarity, 245 mOsm/L)

Per litre: sodium chloride 2.6 g (sodium 75 mmol/L, chloride 65 mmol/L), anhydrous glucose 13.5 g (75 mmol/L), potassium chloride 1.5 g (potassium 20 mmol/L) and trisodium citrate dihydrate 2.9 g (citrate 10 mmol/L).

Preparation: dissolve one full packet in 1 litre of clean (boiled and cooled) water, stir well, do not add sugar or milk, and discard unused solution after 24 hours.

(c)(i) Differential diagnosis of psoriatic arthritis

  • Rheumatoid arthritis: symmetric small-joint polyarthritis sparing the DIP joints, positive rheumatoid factor and anti-CCP, nodules; psoriatic arthritis is usually seronegative, often asymmetric, with DIP disease, dactylitis, enthesitis and nail changes.
  • Axial spondyloarthritis: symmetric sacroiliitis and marginal syndesmophytes; in psoriatic arthritis sacroiliitis is often asymmetric with non-marginal syndesmophytes.
  • Osteoarthritis: Heberden's nodes, no inflammatory features.
  • Gout: acute monoarthritis with urate crystals.
  • Reactive arthritis: follows genitourinary or enteric infection.
  • Enteropathic arthritis (IBD).

Pointers: psoriasis, nail pitting, dactylitis, pencil-in-cup deformity, periostitis, and negative rheumatoid factor; CASPAR criteria (3 points or more) support the diagnosis.

(c)(ii) Management of psoriatic arthritis

Treat to target with a rheumatology–dermatology team.

  • Mild peripheral disease: NSAIDs and intra-articular steroid injections.
  • Persistent arthritis: conventional DMARDs (methotrexate, leflunomide, sulfasalazine).
  • Inadequate response, axial disease or severe skin disease: biologics (TNF inhibitors, IL-17 inhibitors, IL-12/23 or IL-23 inhibitors), or tofacitinib or apremilast.
  • Avoid systemic steroids (psoriasis flare on withdrawal); treat skin disease; physiotherapy, weight loss and smoking cessation; screen for cardiovascular and metabolic comorbidity.

How this answer will be evaluated

Framework: Clinical Sequence (Definition > Aetiology > Features > Investigation > Management)

What earns full marks: Accurate clinical protocols, precise drug dosages, clear differentiation of conditions.

Evaluation rubric

Each sub-part is marked on its own, against the marks and word limit printed on the paper.

  1. (a) Discuss in short the aetiology, diagnosis, treatment and complications of cirrhosis of liver 20 marks

    discuss— intro → 3-4 dimensions → example → balanced close

    Must cover

    • Aetiology: alcohol, hepatitis B and C, fatty liver disease, autoimmune, biliary and metabolic causes
    • Diagnosis by clinical signs, laboratory tests, ultrasound or elastography, and Child–Pugh or MELD scoring
    • Complications: variceal bleeding, ascites, SBP, encephalopathy, hepatorenal syndrome and hepatocellular carcinoma

    Loses marks

    • Omitting complications
    • Giving only treatment of complications and not of the underlying cause

    Earns more

    • Treating the cause and managing varices with beta-blockers or band ligation
    • Ascites management with salt restriction, diuretics and paracentesis with albumin
    • Lactulose and rifaximin, transplant and six-monthly HCC surveillance

    Extra mark

    • Mentions Wilson disease or alpha-1 antitrypsin deficiency in aetiology
  2. (b)(i) Assess the severity of illness in the 15-month-old child with vomiting and diarrhoea 4 marks

    explain— definition/context → points in order → small example → short close

    Must cover

    • Severe dehydration (Plan C) on WHO or IMCI criteria
    • Lethargy and inability to drink as the defining signs
    • Estimated deficit above 10% of body weight

    Loses marks

    • Classifying as some dehydration
    • Inventing signs not given in the case

    Earns more

    • Assessing eyes, thirst and skin pinch
    • Looking for shock

    Extra mark

    • Notes weight deficit above 1 kg
  3. (b)(ii) Write the fluid management in the first 3 hours 4 marks

    explain— definition/context → points in order → small example → short close

    Must cover

    • IV Ringer's lactate or normal saline 100 mL/kg
    • 30 mL/kg in the first 30 minutes, then 70 mL/kg over 2.5 hours
    • Reassessment every 15–30 minutes

    Loses marks

    • Starting with ORS alone
    • Giving 5% dextrose alone as resuscitation fluid

    Earns more

    • Total volume of 1,000 mL for 10 kg
    • Starting ORS as soon as the child can drink

    Extra mark

    • Notes the different schedule for infants under 12 months
  4. (b)(iii) Write the treatment guidelines after 3 hours if signs of dehydration persist 4 marks

    explain— definition/context → points in order → small example → short close

    Must cover

    • Reassess hydration status
    • Repeat IV fluids if severe dehydration persists or switch to Plan B for some dehydration
    • Zinc 20 mg daily for 14 days with continued feeding

    Loses marks

    • Stopping feeds
    • Stopping fluids without reassessment

    Earns more

    • Plan B: ORS 75 mL/kg over 4 hours
    • Plan A once rehydrated, with ORS after each loose stool

    Extra mark

    • Mentions counselling and follow-up
  5. (b)(iv) Write the composition and preparation of WHO oral rehydration salts 8 marks

    explain— definition/context → points in order → small example → short close

    Must cover

    • Sodium chloride 2.6 g, glucose 13.5 g, potassium chloride 1.5 g and trisodium citrate 2.9 g per litre
    • Ion concentrations: sodium 75, chloride 65, glucose 75, potassium 20 and citrate 10 mmol/L
    • Osmolarity 245 mOsm/L

    Loses marks

    • Giving the old high-osmolarity composition as current
    • Advising dilution in less than 1 litre

    Earns more

    • One packet in 1 litre of clean water
    • Discard after 24 hours

    Extra mark

    • Notes no addition of sugar, milk or salt
    • Notes the older 311 mOsm/L formulation was replaced
  6. (c)(i) Give the differential diagnosis of psoriatic arthritis and how to distinguish it from other conditions 5 marks

    compare— paired headings or point-wise contrast → key differences → significance → conclusion

    Must cover

    • Rheumatoid arthritis, axial spondyloarthritis, osteoarthritis, gout and reactive arthritis
    • Features favouring PsA: psoriasis, DIP disease, dactylitis, enthesitis and nail changes
    • Seronegativity and radiological signs such as pencil-in-cup and periostitis

    Loses marks

    • Calling PsA seropositive
    • Listing diagnoses without distinguishing features

    Earns more

    • Asymmetric oligoarthritis or sacroiliitis
    • CASPAR criteria

    Extra mark

    • Mentions Moll and Wright patterns
    • Mentions enteropathic arthritis
  7. (c)(ii) Discuss the management of psoriatic arthritis 5 marks

    discuss— intro → 3-4 dimensions → example → balanced close

    Must cover

    • Treat-to-target approach with NSAIDs and intra-articular steroids for mild disease
    • Conventional DMARDs: methotrexate, leflunomide, sulfasalazine
    • Biologics and targeted agents for severe or axial disease

    Loses marks

    • Starting with biologics for mild disease
    • Omitting physiotherapy or comorbidity screening

    Earns more

    • TNF, IL-17 and IL-12/23 or IL-23 inhibitors
    • Tofacitinib or apremilast

    Extra mark

    • Notes avoidance of systemic steroids
What "Discuss" is asking you to do

Lay the issue out from more than one side — how it arose, what is claimed for it, what is held against it, and where it now stands. UPSC attaches discuss to broad topics with several live dimensions, so coverage of the dimensions earns more than the strength of your opinion.

Structure that answers it

Set the issue up → the case as it is made → the case against → the dimension both sides leave out → where the balance now lies

Where marks are lost

Listing facts with no thread between them, or arguing one side throughout and calling it a discussion.

All UPSC directive words, compared →

Practice this exact question

Write your answer and it is marked point by point against the model answer above — what you covered, what you missed, what you got wrong.

Evaluate my answer →

More from Medical Science 2021 Paper II

Write this answer and get it marked in about 20 seconds

Free account: 5 AI evaluations a month, marked against the rubric above.

Start free

Already have an account? Log in